McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams

Pyritinol

Pyritinol has been used clinically in a wide range of disorders including cerebral circulatory disorders, alcoholism, dyslexia, behavioral disorders in children, and stroke.

1. Pyritinol may be useful in various forms of dementia, head injury, stroke aftermath, coma, and cerebral circulatory disorders.
2. Pyritinol may be useful as an anti-brain aging, cognitive enhancing agent.
3. Pyritinol may be useful as an aid to improved memory, concentration, alertness and information processing in both young and old.
4. Pyritinol may be useful in Attention Deficit Disorder (ADD).
                                                                                              www.pyritinol.org          pyritinol article            to order 

Pyritinol has been used following head injury and cerebral trauma. Pyritinol has reduced the normal high death rate in such cases and has rapidly returned coma patients to more or less normal waking consciousness, even when the brain injuries were so severe the patient ultimately died.

Pyritinol has the ability to enhance glucose transport through the blood-brain barrier. Although the brain is usually less than 2% of total bodyweight, the brain uses about 20% of the body's total energy production. Under normal, non-fasting conditions, the brain can only 'burn' glucose (sugar) for fuel. Unlike virtually all other body cells, nerve cells cannot use fat as an energy fuel. Brain cells also cannot store any significant amount of glucose - they are completely dependent upon a continuous delivery of glucose from the blood, through the blood-brain barrier. Thus, brain glucose uptake is a major rate-limiting factor for crucial brain energy production. Pyritinol has the ability to increase glucose transport through the blood-brain barrier.


to order
 

                         BRAIN PRODUCTS              for wholesale prices   click          
Order  Acetyl L-Carnitine 500 mg 60 caps $19.95
Order  Aniracetam 750 mg 30 caps 26.95
Order  CDP-Choline 200 mg 60 caps 19.95
Order  Centrophenoxine 250 mg 60 caps 19.95
Order  Deprenyl  liquid         not shipped to the USA 300 mg 12 mL 75.00
Order  DMAE 125 mg 100 caps 5.95
Order  Galantamine   8 mg 30 caps 23.95
Order  Huperzine A 100 mcg 60 caps 9.95
Order  Idebenone 45 mg 60 caps 29.95
Order  Phosphatidylserine 100 mg 60 caps 29.95
Order  Picamilon 100 mg 60 caps 29.95
Order  Piracetam 800 mg 60 caps 16.95
Order  Pyritinol 200 mg 60 caps 14.95
Order  Vinpocetine        6 bottles @ $12 = $72 20 mg 60 caps 19.95
Order  Get SmartTM    as reported in Wired magazine 715 mg 60 caps 29.95

        ingredients in 2 capsules
Aniracetam 500 mg    more potent analog of piracetam
Centrophenoxine 300 mg    raises brain acetylcholine levels
Pyritinol 300 mg    improves memory, concentration
Picamilon 100 mg    increases circulation to the brain
Piracetam 100 mg    increases communication between the 2 brain hemispheres
Sulbutiamine 100 mg   
Vinpocetine 10 mg

   dilates blood vessels in the brain
Oxiracetam 10 mg    more potent analog of piracetam
Idebenone 10 mg    increases nerve growth factor (NGF) in the brain
Galantamine 300 mcg    prevents build up of beta amyloid plaque in the brain
Huperzine A 100 mcg    extends the life of acetylcholine in the brain


Smart Nutrition
1765 Garnet Ave #66
San Diego, CA 92109
 phone: 858-270-7907
 smart@smartnutrition.info
 
 

REFERENCES

  K. Kitamura (1981) "Therapeutic Effect of Pyritinol on Sequelae of Head Injuries" J Int Med Res 9, 215-21.

  G. Dalle Ore et al (1980) "The Influence of the Administration of Pyritinol on the Clinical Course of Traumatic Coma", J Neuroserg Sci 24, 1-8.

  E.M. Lemmel (1993) "Comparison of Pyritinol and Auranofin in the Treatment of Rheumatoid Arthritis" Br J Rheumatol 32, 375-82.

  I. Hindmarch et al (1990) "Psychpharmacalogical Effects of Pyritinol in Normal Volunteers" Neuropsychobiol 24, 159-64.

  A. Pavlik & J. Pilar (1989) "Protection of Cell Proteins Against Free-Radical Attack by Nootropic Drugs: Scavenger Effects of Pyritinol Confirmed by Electron Spin Resonance Spectroscopy" Nueropharmacol 28, 557-61.

  S. Hoyer et al (1977) "Effect of Pyritinol-HCL on Blood Flow and Oxidative Metabolism of the Brain in Patients with Dementia" Arzneim Forsch/Drug Res 27, 671-74.

  J. Elferink & B. de Koster (1993) "Differential Stimulation of Neutrophil Functions by Pyritinol" Int J Immunopharmac 15, 641-46.

  H.-R. Olpe et al (1985) "Locus Coeruleus as a Target for Psychogeriatric Agents" Ann NY Acad Sci 444, 394-405.

  G. Logue et al (1974) "The Effects of Pyrithioxine on the Behavior and Intellectual Functioning of Learning-Disabled Children" S.Afr Med J 48, 2245-46.

  D. Lane O’Kelly (1975) "Pyritinol in the Treatment of Chronic Alcoholics" J Int Med Res 3, 323-27.

  K. Fischhof et al (1992) "Therapeutic Efficacy of Pyritinol in Patients with Senile Dementia of the Alzheimer Type (SDAT) and Multi-Infarct Dementia (MID)" Neuropsychobiol 26, 65-70.

  A. Cooper & R. Magnus (1980) "A Placebo-Controlled Study of Pyritinol in Dementia" Pharmatherapeutica 2, 317-22.

  R. Branconnier (1983) "The Efficacy of the Cerebral Metabolic Enhancers in the Treatment of Senile Dementia" Psychopharmacol Bull 1983 Spring;19(2):212-9.
to order
 

 

 

Hit Counter